A Cancer Cell Program Promotes T Cell Exclusion and Resistance to Checkpoint BlockadeLivnat Jerby‐Arnon, Charles H. Yoon, Claire Margolais et al.|Cell|2018Cited by 1.5k
Genomic correlates of response to immune checkpoint blockade in microsatellite-stable solid tumorsDiana Miao, Eliezer M. Van Allen, Claire A. Margolis et al.|Nature Genetics|2018Cited by 701
Skin cancer classification via convolutional neural networks: systematic review of studies involving human expertsSarah Haggenmüller, Mildred Sergon, Roman C. Maron et al.|European Journal of Cancer|2021Cited by 246
ESMO consensus conference recommendations on the management of metastatic melanoma: under the auspices of the ESMO Guidelines CommitteeUlrich Keilholz, Olivier Michielin, P.A. Ascierto et al.|Annals of Oncology|2020Cited by 232
Combination of encorafenib and binimetinib followed by ipilimumab and nivolumab versus ipilimumab and nivolumab in patients with advanced melanoma with BRAFV600E or BRAFV600K mutations (EBIN): an international, open-label, randomised, controlled, phase 2 studyCaroline Robert, Alexander C. J. van Akkooi, Michal Kiciński et al.|The Lancet Oncology|2025Cited by 10